A ten-year retrospective California Poison Control System experience with possible amatoxin mushroom calls.
Timothy E AlbertsonRichard F ClarkCraig G SmollinRais VohraJustin C LewisJames A ChenowethJacqueline C StockingPublished in: Clinical toxicology (Philadelphia, Pa.) (2023)
The California Poison Control System has relatively few amatoxin-containing mushroom ingestion calls that result in hospitalization but those that are reported mostly occur in Northern California. Treatment bias towards the sickest patients may explain the association of intravenous fluid use or treatment with acetylcysteine or silibinin with meeting the composite outcome. The initial presence of elevated hepatic aminotransferase activity and international normalized ratios are poor prognostic indicators and are likely reflective of late presentation, an advanced toxic phase of amatoxin poisoning, and/or delays in time to obtain poison center consultation.